Literature DB >> 1934441

Intraoperative ultrasonographic evaluation of the ascending aorta in 100 consecutive patients undergoing cardiac surgery.

V G Davila-Roman1, B Barzilai, T H Wareing, S F Murphy, N T Kouchoukos.   

Abstract

Dislodgement of atheromatous plaque from the ascending aorta following manipulation is one of the principal causes of stroke following cardiac surgery. To define clinical correlates that predict the presence of severe atherosclerosis, we performed ultrasonographic evaluation of the ascending aorta at the time of cardiac surgery in 100 consecutive patients. The ascending aorta was divided into three equal segments for analysis, and the severity of atherosclerosis was determined as mild when intimal thickening (less than 3 mm) was localized to one segment, moderate when intimal thickening (greater than 3 mm) was present in one or two segments, and severe when intimal thickening (greater than 3 mm) was present throughout the entire circumference in all three segments. Thirty-eight percent of the studies were normal, mild atherosclerosis was present in 33%, moderate atherosclerosis in 19%, and severe atherosclerosis in 10% of the patients. Palpation of the ascending aorta to detect atherosclerosis significantly underestimated the presence (p less than 0.001) and severity (p less than 0.001) of atherosclerosis when compared with ultrasonography. Age, carotid artery disease, diabetes, gender, smoking, and hypertension were evaluated for their ability to discriminate between normal and severely atherosclerotic aortas. Stepwise logistic regression analysis showed age (p less than 0.02) and diabetes (p less than 0.04) to be significant independent predictors of the presence of severe atherosclerosis in the ascending aorta. Based on the ultrasonographic findings, the operative procedure was altered to reduce the risk of embolization in 17% of the patients. We conclude that high-resolution images of the ascending aorta for identification of atherosclerosis can be obtained by ultrasonography.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1934441

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Pulsatile versus non-pulsatile flow to reduce cognitive decline after coronary artery bypass surgery: A randomized prospective clinical trial.

Authors:  Koray Aykut; Gokhan Albayrak; Mehmet Guzeloglu; Eyup Hazan; Muge Tufekci; Ipek Erdoğan
Journal:  J Cardiovasc Dis Res       Date:  2013-06-18

2.  A no-touch technique for calcified ascending aorta during coronary artery surgery.

Authors:  B Akpinar; M Güden; I Sanisoğlu; C Konuralp; O Yilmaz; B Sönmez
Journal:  Tex Heart Inst J       Date:  1998

3.  Risks of Stroke After Coronary Artery Bypass Graft - Recent Insights and Perspectives.

Authors:  Tullio Palmerini; Carlo Savini; Marco Di Eusanio
Journal:  Interv Cardiol       Date:  2014-04

4.  [Epicardial echocardiography intraoperative diagnostic utility to assess valve function].

Authors:  T Edrich; T W Felbinger; P Rosenberger; S K Shernan; H K Eltzschig
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

5.  Coronary-pulmonary arteriovenous fistula used as proximal anastomotic site for saphenous vein grafts in patient with porcelain aorta.

Authors:  Aaron S L Wong; Yeow-Leng Chua; Charles N S Chan
Journal:  Tex Heart Inst J       Date:  2003

6.  Risk factors of atheromatous aorta in cardiovascular surgery.

Authors:  Fernando A Atik; Isaac Azevedo Silva; Claudio Ribeiro da Cunha
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Oct-Dec

Review 7.  Imaging Techniques for Diagnosis of Thoracic Aortic Atherosclerosis.

Authors:  Wouter W Jansen Klomp; George J Brandon Bravo Bruinsma; Arnoud W van 't Hof; Jan G Grandjean; Arno P Nierich
Journal:  Int J Vasc Med       Date:  2016-02-04

8.  Extraanatomical coronary artery bypass grafting in patients with severely atherosclerotic (Porcelain) aorta.

Authors:  Gokce Sirin; Kamil Sarkislali; Murat Konakci; Ergun Demirsoy
Journal:  J Cardiothorac Surg       Date:  2013-04-15       Impact factor: 1.637

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.